Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 + GHRP-2 Stack Protocol — Path To Peptides

Complete CJC-1295 + GHRP-2 stack protocol: synergistic GH release dosing, reconstitution guide, growth hormone optimization timeline, and stacking strategy.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Protocol Overview

Dosing Protocol

Introductory

100 mcg

2x daily (AM + PM)

2 weeks

Standard

3x daily (AM, post-WO, PM)

12-16 weeks

Advanced

200 mcg

Saturation

1 mcg/kg

1-2 mcg/kg

3x daily

Key principle: Both peptides must be taken on an empty stomach. Fat and carbohydrates blunt GH release. Wait at least 30 minutes after injection before eating. The pre-bed dose is most important as it amplifies the natural nocturnal GH surge.

Reconstitution Guide

CJC-1295 no DAC (2mg vial)

Diluent: 2mL bacteriostatic water

Concentration: 1mg/mL (1,000mcg/mL)

100mcg dose: 10 units on insulin syringe

Vial yield: 20 doses at 100mcg

GHRP-2 (5mg vial)

Diluent: 2.5mL bacteriostatic water

Concentration: 2mg/mL (2,000mcg/mL)

100mcg dose: 5 units on insulin syringe

Vial yield: 50 doses at 100mcg

Note: Can be drawn into same syringe as CJC-1295

Administration Guide

Injection Protocol

Syringe: 29-31ga insulin syringe

Sites: Abdominal fat, thigh, deltoid

Combine: Draw both peptides into one syringe

Fasting: No food 30 min before/after injection

Best timing: AM fasted, post-workout, 30 min before bed

Storage & Handling

Pre-reconstitution: Room temp or refrigerated

Post-reconstitution: Refrigerate at 2-8°C

Stability: 28-30 days once reconstituted

Do not freeze: Freezing damages reconstituted peptides

Expected Timeline

Side Effects & Monitoring

Common Side Effects

Increased appetite/hunger (GHRP-2 ghrelin effect)

Water retention in first 1-2 weeks

Tingling/numbness in extremities (transient)

Mild head rush immediately post-injection

Vivid dreams/deeper sleep

GHRP-2 has stronger appetite stimulation than GHRP-6 but less than MK-677. This can be managed with timing.

Precautions

Monitor blood glucose (GH can reduce insulin sensitivity)

GHRP-2 raises cortisol and prolactin transiently

Avoid exceeding saturation dose (diminishing returns)

Not recommended with active cancer (GH/IGF-1 proliferative)

Cycle appropriately to maintain pituitary sensitivity

Stacking Recommendations

Compatible Compounds

Ipamorelin: Can alternate with GHRP-2 for lower cortisol/prolactin

BPC-157: Enhanced recovery and gut health

TB-500: Tissue repair synergy

AOD-9604: Additional fat loss via hGH fragment pathway

MK-677: Oral GH secretagogue for off-injection days

Popular Stacks

GH Optimization: CJC/GHRP-2 3x/day + MK-677 25mg at night

Recovery: CJC/GHRP-2 2x/day + BPC-157 + TB-500

Recomp: CJC/GHRP-2 3x/day + AOD-9604 300mcg

Blood Work Recommendations

GH / IGF-1

IGF-1, GH serum

Baseline, Week 6, Week 12

Metabolic Panel

Fasting glucose, insulin, HbA1c

Baseline, Week 8, Week 16

Hormonal

Cortisol, prolactin, thyroid (TSH, fT3, fT4)

Baseline, Week 8

Liver/Kidney

CMP, ALT, AST, creatinine

Baseline, Week 12

IGF-1 is the primary marker for GH axis optimization. Monitor fasting glucose as chronic GH elevation can reduce insulin sensitivity. Check prolactin if using GHRP-2 long-term.

Related Tools & Resources

Related Resources

Connected topics

Follow this recovery question